Purchase Order HHSN302201600184P

<p>The National Human Genome Research Institute awarded a purchase order to Roche Diagnostics Corporation on February 19, 2016, with a ceiling value of $6,324.80 and firm fixed pricing. Performance is located in Bethesda, Maryland. The order was set to complete on December 23, 2020.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Roche Diagnostics Corporation on May 5, 2015, with a ceiling value of $3,689.35 under firm fixed-price terms. Performance is located in North Bethesda, Maryland, with a completion date of June 5, 2015. The specific goods or services procured are not detailed in the source material.</p>

This $9,173 firm fixed price purchase order was awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the U.S. Department of Health and Human Services, to Roche Diagnostics Corporation on August 22, 2016. The award does not have a set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services, has provided critical care analyzers, reagents, test kits,...

<p>The National Human Genome Research Institute awarded a purchase order to the University of Rochester for testing kits valued at $1,495.24, effective September 20, 2016, with ultimate completion by December 21, 2020. Performance takes place in Rochester, New York. The order carries firm fixed-price terms and uses no small business set-aside.</p>

This federal contract award was made by the National Human Genome Research Institute (NHGRI), a civilian agency, to Roche Diagnostics Corporation. The $23,500 fixed-price purchase order is for the delivery of unspecified products or services from Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated items. The contract has no set-aside designation. Roche Diagnostics has previously received awards from the Department of...

This is a $9,734.40 firm fixed-price purchase order awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Roche Diagnostics Corporation. The contract does not have a set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, has received numerous federal contract awards, including through General Services Administration (GSA) Schedule contracts,...

<p>The NIH Clinical Center awarded a purchase order to Roche Diagnostics Corporation on April 18, 2019, with a ceiling value of $79,779.95 for in vitro diagnostic products and services. Place of performance is Castleton, Indiana. The order carries a firm fixed-price structure and no set-aside designation. Ultimate completion is scheduled for September 30, 2019.</p>

<p>The National Human Genome Research Institute issued a purchase order to Bio-Rad Laboratories, Inc. on May 19, 2016, with a ceiling value of $17,418.48 for firm fixed-price laboratory equipment and supplies. Place of performance is Bethesda, Maryland. The order ultimate completion date is December 22, 2020. No set-aside was used.</p>

This is a firm fixed-price Blanket Purchase Agreement (BPA) call order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract is for the procurement of Roche Diagnostics' GS FLX Titanium Sequencing Kits, which are used for next-generation genome sequencing. The award has a ceiling value of $24,899.20 and an ultimate completion date of December 31, 2012. Roche...

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $4,452.00 on September 15, 2017, for firm fixed price commercial items. Place of performance is Bethesda, Maryland. The order has an ultimate completion date of December 31, 2017. No set-aside was used.</p>